Bianca Rocca/LinkedIn
Jun 29, 2026, 13:18
Bianca Rocca: New Expert Opinion On the Evolving Debate on Factor XI as a Therapeutic Target
Bianca Rocca, Editor in Chief at European Heart Journal Cardiovascular Pharmacotherapy, shared on LinkedIn about a recent article by Valeria Caso et al, published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
”Delighted to share this just-released opinion by leading international experts addressing the current and evolving debate on Factor XI as a pharmacological target.
I hope you enjoy the article, and I wish everyone a great week!”
Title: Current opinion: the OCEANIC trial journey: from failure to breakthrough?
Authors: Valeria Caso, Hugo ten Cate, Isabelle C van Gelder
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering